Telmisartan (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Telmisartan drug offered from Actavis Pharma, Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Telmisartan |
SUBSTANCE NAME: | TELMISARTAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-01-08 |
END MARKETING DATE: | 0000-00-00 |
Telmisartan HUMAN PRESCRIPTION DRUG Details:
Item Description | Telmisartan from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2014-01-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-3292_d1d1de1c-f5fc-4745-8f04-73f00db617d8 |
PRODUCT NDC: | 0591-3292 |
APPLICATION NUMBER: | ANDA078710 |
Other TELMISARTAN Pharmaceutical Manufacturers / Labelers: